Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states
申请人:AstraZeneca AB (Publ)
公开号:EP2778156A1
公开(公告)日:2014-09-17
The present invention provides a compound of a formula (I):
wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE4 mediated disease state.
本发明提供了一种式 (I) 的化合物:
其中的变量在本文中定义;提供了制备这种化合物的工艺;并提供了这种化合物在治疗 PDE4 介导的疾病状态中的用途。